01/09/2026
Airlangga Cardiology Dept. :
Do your patients still struggle with angina
or heart failure despite optimal therapy?
The medications are optimized. Revascularization has
been performed. Yet the symptoms remain.
What comes next?
Discover how Enhanced External Counterpulsation (EECP) can become a valuable adjunctive therapy to improve symptoms, functional capacity, and quality of life in appropriately selected cardiovascular patients.
Join us at ACSA 2026: Cardiac Prevention & Rehabilitation Workshop
Beyond Medication and Revascularization: The Role of EECP in Contemporary Cardiovascular Care Gain practical insights from experts on:
🫀Why some patients remain symptomatic despite optimal therapy
🫀The mechanisms, evidence, and patient selection for EECP
🫀Practical implementation and future perspectives of EECP
📅17 Saturday, September 5th, 2026
📍Four Points Hotel Surabaya
Seats are limited-don't miss this opportunity to elevate your cardiovascular practice.
👉 Register now at www.acsasurabaya.com
☎️Contact:
Deya +62812-8483-6665
Sri Rejeki +62816-5421-216
Yunanda +62888-3208-113
